"The U.S. Food and Drug Administration today approved Gardasil 9 (Human Papillomavirus 9-valent Vaccine, Recombinant) for the prevention of certain diseases caused by nine types of Human Papillomavirus (HPV). Covering nine HPV types, five more HPV"...
DOSAGE AND ADMINISTRATION
PODOCON-25® (podophyllin) IS TO BE APPLIED ONLY BY A PHYSICIAN. IT IS NOT TO BE DISPENSED TO THE PATIENT. SHAKE WELL.
Thoroughly cleanse affected area. Use supplied applicator to apply Podocon-25® (podophyllin) sparingly to lesion. Avoid contact with healthy tissue. Allow to dry thoroughly. Only intact (no bleeding) lesions should be treated. As podophyllin is a powerful caustic and severe irritant, it is recommended the first application of Podocon-25® (podophyllin) be left in contact for only a short time (30-40 minutes) to determine patient's sensitivity. To avoid systemic absorption, time of contact should be minimum time necessary to produce the desired result (1 to 4 hours, depending on condition of lesion and of patient), the physician developing his/her own experience and technique. Large areas or numerous warts should not be treated at once.
After treatment time has elapsed, remove dried Podocon-25® (podophyllin) thoroughly with alcohol or soap and water.
Podocon-25® (podophyllin) is available in 15-ml bottles with tapered tip applicator attached inside cap. NDC 0574-0601-15
Store at room temperature 15°-30° C (59°-86° F) in tight, light-resistant containers.
4) Medical Letter; Vol 26, New Rochelle, N.Y., 1984, p10.
Paddock Laboratories, Inc. Minneapolis, MN 55427. (08-05). FDA Rev date: n/aThis monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 9/15/2008
Additional Podocon-25 Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.